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Re: Care of Patients Who Are Worried about
Mercury Poisoning from Dental Fillings
To the Editor: In the Research Letter by Vearrier and
Greenberg,1 the authors elegantly describe a 37-year-
old woman with clinically suspected overexposure to
mercury from her mercury-containing dental amalgam
ﬁllings. She also had thyroid dysfunction. In this con-
text, concerns regarding the risk of mercury amalgam
were raised by her wellness doctor after the adminis-
tration of the intravenous chelating agent dimercapto-
succinic acid, resulting in a marked increase of urinary
excretion of mercury.1 Although the authors presented
data indicating that the urinary mercury levels during
re-evaluation were within the normal reference range
(4 g/L; upper limit value, 20 g/L),1 we are
surprised that the authors did not include the results of
mercury concentrations in whole blood that could
have conﬁrmed the absence of continuous overexpo-
sure to mercury from her dental amalgam ﬁllings.
This important point is not well understood yet.
Previous studies have demonstrated that there is a
signiﬁcant correlation between mercury-containing
amalgam ﬁllings and both plasma and blood concen-
trations of mercury in adults, and positive associations
have been observed.2 Therefore, in addition to the
urinary mercury levels as written by Vearrier and
Greenberg,1 we suggest that blood and/or plasma level
determinations also should be performed as a screen
for patients with a suspected adverse event caused by
mercury-containing dental amalgam ﬁllings. Second,
the ﬁndings of a preliminary epidemiologic and aller-
gologic study of adverse reactions to mercury amalgam
provides evidence that the 30.89% of 259 patients had
an allergic reaction to mercury compounds, in aggre-
gate.3 In our experience4,5 and that of others,6 the
thyroid would seem to be a primary target organ of
mercury released from mercury amalgams. Because of
these reference data,4–6 the wellness physician may
have supposed a link between his patient’s thyroid
disorder and her dental amalgam ﬁllings. Reassuring
our patients that they are not being poisoned by mer-
cury from their amalgam can be very helpful because it
is a very rare event.7
However, we should provide patients and physi-
cians with correct information about the potential of
toxicology tests, including the patch test, for adverse
events potentially related to mercury-containing den-
tal amalgams.3 The case study of Vearrier and Green-
berg1 reminds us that chelation therapy is not needed
when the toxicological tests results of a patient with
suspected overexposure to mercury amalgam are below
the reference range.
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The above letter was referred to the author of the article
in question, who offers the following reply.
476 JABFM July–August 2011 Vol. 24 No. 4 http://www.jabfm.org
